Current guidelines recommend intramuscular administration of epinephrine as the first-line drug for the emergency treatment of severe allergic reactions (anaphylaxis), but no randomized trial evidence supports this consensus.
Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register / Grabenhenrich, Linus B; Dölle, Sabine; Ruëff, Franziska; Renaudin, Jean-Marie; Scherer, Kathrin; Pföhler, Claudia; Treudler, Regina; Koehli, Alice; Mahler, Vera; Spindler, Thomas; Lange, Lars; Bilò, Maria Beatrice; Papadopoulos, Nikolaos G; Hourihane, Jonathan O B; Lang, Roland; Fernández-Rivas, Montserrat; Christoff, George; Cichocka-Jarosz, Ewa; Worm, Margitta. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE. - ISSN 2213-2198. - 6:6(2018), p. 1898-1906.e1. [10.1016/j.jaip.2018.02.026]
Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register
Bilò, Maria BeatriceMembro del Collaboration Group
;
2018-01-01
Abstract
Current guidelines recommend intramuscular administration of epinephrine as the first-line drug for the emergency treatment of severe allergic reactions (anaphylaxis), but no randomized trial evidence supports this consensus.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
